ArticlePloS one2015

Overexpression of the novel senescence marker β-galactosidase (GLB1) in prostate cancer predicts reduced PSA recurrence.

Jennifer Wagner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.